Bespoke Extracts (BSPK) Gross Profit (QoQ) (2019 - 2025)
Bespoke Extracts (BSPK) Gross Profit (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.58 Bn | 86.72 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.33 Bn | 30.39 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.93 Bn | 16.62 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 18.57% |
| Jun 30, 2025 | 78.28% |
| Mar 31, 2025 | -14.29% |
| Dec 31, 2024 | 12.39% |
| Sep 30, 2024 | 8.37% |
| Jun 30, 2024 | 3.45% |
| Mar 31, 2024 | -37.21% |
| Dec 31, 2023 | 66.01% |
| Sep 30, 2023 | 38.53% |
| Jun 30, 2023 | 586.40% |
| Mar 31, 2023 | -77.71% |
| Dec 31, 2022 | 71,532.31% |
| Sep 30, 2022 | 99.86% |
| Jun 30, 2022 | -2,192.23% |
| Nov 30, 2021 | -91.01% |
| Aug 31, 2021 | 207.96% |
| May 31, 2021 | 236.62% |
| Feb 28, 2021 | -62.51% |
| Nov 30, 2019 | 101.36% |
| Aug 31, 2019 | -9,748.79% |